Johnson & Johnson will stop selling talc-based baby powder globally in 2023

His talcum powderwhich has not been sold in the United States and Canada since 2020, is at the center of tens of thousands of lawsuits brought by women who developed ovarian cancer after using ordinary talcum powder

Johnson & Johnson says it remains confident in the safety of the product. But, in a statement on Friday, the company said it would stop selling talcum powder globally next year as part of a “global portfolio review”.

“We are continuously evaluating and optimizing our portfolio to best position the business for long-term growth,” the company said in a statement. “This transition will help simplify our product offerings, deliver sustainable innovation, and meet the needs of our consumers, customers, and ever-changing global trends.”

A handful of talcum powder companies have put warning labels on their products, but Johnson & Johnson (JNJ) argued that such a label would be confusing, as it defended its product. Some scientific studies have shown that women have an increased risk of ovarian cancer with the use of talc in the genital area, but others have not.
Lawsuits have been filed against the company alleging asbestos in its talcum powder causes cancer. A St. Louis jury delivered to $4.7 billion verdict against the company in 2018, claiming the company was negligent and failed to warn consumers of the possible health risks of its baby powder.

“Our position on the safety of our cosmetic talc remains unchanged. We strongly support decades of independent scientific analysis from medical experts around the world confirming that Johnson’s talc-based baby powder is safe, contains no asbestos and does not cause cancer,” he said in Friday’s announcement.